Circular RNA UBAP2 Facilitates the Cisplatin Resistance of Triple-negative Breast Cancer Via MicroRNA-300/anti-silencing Function 1B Histone Chaperone/PI3K/AKT/mTOR Axis

Overview

Journal Bioengineered

Date 2022 Mar 9

PMID 35263216

Authors

Leiming Wang

Xi Yang

Fei Zhou

Xuesi Sun

Shulin Li

Affiliations

Soon will be listed here.

Abstract

Circular RNAs (CircRNAs) have attracted increasing attention in the diagnosis and treatment of human cancers. CircUBAP2 has been identified to promote the progression of triple-negative breast cancer (TNBC), but the function of circUBAP2 in the cisplatin (DDP) resistance of TNBC remains obscure. Our investigation showed that circUBAP2 was significantly upregulated in DDP-resistant TNBC and TNBC sensitivity to DDP could be enhanced by silencing of circUBAP2. Moreover, circUBAP2 was revealed to be a ceRNA for miR-300 to upregulate the expression of anti-silencing function 1B histone chaperone (ASF1B). The effect of circUBAP2/miR-300/ASF1B axis on DDP resistance of TNBC was evaluated by rescue experiments, which demonstrated that circUBAP2 inhibited TNBC sensitivity to DDP through miR-300/ASF1B axis. Furthermore, it was discovered that ASF1B activated PI3K/AKT/mTOR signaling to facilitate the DDP resistance of TNBC cells. In summary, this research revealed a novel regulatory mechanism that circUBAP2 functioned as ceRNA of miR-300 to upregulate ASF1B, which further triggered the PI3K/AKT/mTOR (PAM) signaling to enhance the DDP resistance of TNBC.

Citing Articles

circ_0004662 contributes to colorectal cancer progression by interacting with hnRNPM.

Zhang Y, Wang J, Quan R, Lyu L Int J Oncol. 2025; 66(2.

PMID: 39821691 PMC: 11753766. DOI: 10.3892/ijo.2025.5720.

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.

Liu Y, Zou Y, Ye Y, Chen Y Cancer Med. 2024; 13(22):e70410.

PMID: 39558881 PMC: 11574469. DOI: 10.1002/cam4.70410.

DNA damage response-related ncRNAs as regulators of therapy resistance in cancer.

Gao Z, Luan X, Wang X, Han T, Li X, Li Z Front Pharmacol. 2024; 15:1390300.

PMID: 39253383 PMC: 11381396. DOI: 10.3389/fphar.2024.1390300.

Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review.

Mehrtabar E, Khalaji A, Pandeh M, Farhoudian A, Shafiee N, Shafiee A Med Oncol. 2024; 41(9):222.

PMID: 39120634 DOI: 10.1007/s12032-024-02469-4.

Circular RNA circ_ARHGEF28 inhibits MST1/2 dimerization to suppress Hippo pathway to induce cisplatin resistance in ovarian cancer.

Lei R, Long Y, Li Q, Xie Q, Ling X, Xie M Cancer Cell Int. 2024; 24(1):256.

PMID: 39034401 PMC: 11264966. DOI: 10.1186/s12935-024-03451-w.

References

Sang Y, Chen B, Song X, Li Y, Liang Y, Han D . circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Mol Ther. 2019; 27(9):1638-1652. PMC: 6731174. DOI: 10.1016/j.ymthe.2019.05.011. View

Li D, Ji H, Niu X, Yin L, Wang Y, Gu Y . Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. Cancer Sci. 2019; 111(1):47-58. PMC: 6942430. DOI: 10.1111/cas.14230. View

Li H, Li X, Lv Z, Cai M, Wang G, Yang Z . Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status. Cancer Med. 2020; 9(24):9554-9570. PMC: 7774739. DOI: 10.1002/cam4.3543. View

Chen F, Guo L, Di J, Li M, Dong D, Pei D . Circular RNA ubiquitin-associated protein 2 enhances autophagy and promotes colorectal cancer progression and metastasis via miR-582-5p/FOXO1 signaling. J Genet Genomics. 2021; 48(12):1091-1103. DOI: 10.1016/j.jgg.2021.07.017. View

Lee K, Giltnane J, Balko J, Schwarz L, Guerrero-Zotano A, Hutchinson K . MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation. Cell Metab. 2017; 26(4):633-647.e7. PMC: 5650077. DOI: 10.1016/j.cmet.2017.09.009. View

Hong W, Xue M, Jiang J, Zhang Y, Gao X . Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020; 39(1):149. PMC: 7397626. DOI: 10.1186/s13046-020-01648-1. View

Liu X, Jiang W, Ma D, Ge L, Yang Y, Gou Z . SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer. Theranostics. 2020; 10(24):10940-10956. PMC: 7532662. DOI: 10.7150/thno.45207. View

Ediriweera M, Tennekoon K, Samarakoon S . Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance. Semin Cancer Biol. 2019; 59:147-160. DOI: 10.1016/j.semcancer.2019.05.012. View

Shorning B, Dass M, Smalley M, Pearson H . The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. Int J Mol Sci. 2020; 21(12). PMC: 7350257. DOI: 10.3390/ijms21124507. View

10.

Hu H, Zhu J, Zhong Y, Geng R, Ji Y, Guan Q . PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K/AKT/mTOR signaling pathway. Ann Transl Med. 2021; 9(5):410. PMC: 8033310. DOI: 10.21037/atm-21-698. View

11.

Haga Y, Higashisaka K, Yang L, Sekine N, Lin Y, Tsujino H . Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer. Biochem Biophys Res Commun. 2020; 533(4):672-678. DOI: 10.1016/j.bbrc.2020.09.143. View

12.

Kang Y, Zhang Y, Sun Y, Wen Y, Sun F . MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition. Onco Targets Ther. 2018; 11:5657-5666. PMC: 6141125. DOI: 10.2147/OTT.S173236. View

13.

Liu B, Tian Y, Chen M, Shen H, Xia J, Nan J . CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular Carcinoma. Front Cell Dev Biol. 2021; 9:675043. PMC: 8258265. DOI: 10.3389/fcell.2021.675043. View

14.

Mbianda J, Bakail M, Andre C, Moal G, Perrin M, Pinna G . Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity. Sci Adv. 2021; 7(12). PMC: 7978421. DOI: 10.1126/sciadv.abd9153. View

15.

Jiangqiao Z, Tao Q, Zhongbao C, Xiaoxiong M, Long Z, Jilin Z . Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma. Biochem Biophys Res Commun. 2019; 511(1):165-172. DOI: 10.1016/j.bbrc.2019.02.060. View

16.

Wang S, Li Q, Wang Y, Li X, Wang R, Kang Y . Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway. Biochem Biophys Res Commun. 2018; 505(4):996-1002. DOI: 10.1016/j.bbrc.2018.10.026. View

17.

Zhang J, Xie T . Ghrelin inhibits cisplatin-induced MDA-MB-231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling. Exp Ther Med. 2020; 19(3):1633-1640. PMC: 7027091. DOI: 10.3892/etm.2019.8398. View

18.

Wu C, Qiu S, Liu P, Ge Y, Gao X . Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. J Ethnopharmacol. 2017; 211:89-100. DOI: 10.1016/j.jep.2017.09.033. View

19.

Dai J, Zhuang Y, Tang M, Qian Q, Chen J . CircRNA UBAP2 facilitates the progression of colorectal cancer by regulating miR-199a/VEGFA pathway. Eur Rev Med Pharmacol Sci. 2020; 24(15):7963-7971. DOI: 10.26355/eurrev_202008_22479. View

20.

Subramani R, Estrada A, Dixon M, Parada M, Rodriguez S, Pedroza D . Pregnancy Inhibits Mammary Carcinogenesis by Persistently Altering the Hypothalamic-Pituitary Axis. Cancers (Basel). 2021; 13(13). PMC: 8267621. DOI: 10.3390/cancers13133207. View